Search research articles
Contact Us
Filters
Showing results (21-30 of 99) with videos related to
Page
of 10
Sort By:
The American Journal of Medicine
|
September 4, 2012
Antihypertensive efficacy of hydrochlorothiazide vs chlorthalidone combined with azilsartan medoxomil
George L Bakris, Domenic Sica, William B White, et al.
Hypertension (Dallas, Tex. : 1979)
|
June 20, 2012
Azilsartan medoxomil plus chlorthalidone reduces blood pressure more effectively than olmesartan plus hydrochlorothiazide in stage 2 systolic hypertension
William C Cushman, George L Bakris, William B White, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)
|
April 27, 2012
Blood pressure-lowering efficacy of the fixed-dose combination of azilsartan medoxomil and chlorthalidone: a factorial study
Domenic Sica, George L Bakris, William B White, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
August 29, 2023
Relationship between quantitative strength and functional outcomes in the phase 2 FORTITUDE-ALS trial
Jeremy M Shefner, Bill Jacobsen, Stuart Kupfer, et al.
Thrombosis and Haemostasis
|
October 2, 2010
A dose-finding study with TAK-442, an oral factor Xa inhibitor, in patients undergoing elective total knee replacement surgery
Jeffrey I Weitz, Charlie Cao, Bengt I Eriksson, et al.
Clinical Pharmacokinetics
|
February 5, 2025
Effect of Hepatic Impairment or Renal Impairment on the Pharmacokinetics of Aficamten
Donghong Xu, Justin D Lutz, Punag Divanji, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
November 8, 2024
Plasma neurofilament analysis in VITALITY-ALS
Tyrell J Simkins, Stuart Kupfer, Fady I Malik, et al.
Clinical and Translational Science
|
April 9, 2025
Clinical Evaluation of the Effect of Aficamten on QT/QTc Interval in Healthy Participants
Neha Maharao, Donghong Xu, Tyrell J Simkins, et al.
The American Journal of Cardiology
|
September 26, 2006
Predictors of development of diabetes mellitus in patients with coronary artery disease taking antihypertensive medications (findings from the INternational VErapamil SR-Trandolapril STudy [INVEST])
Rhonda Cooper-Dehoff, Jerome D Cohen, George L Bakris, et al.
Journal of Neuromuscular Diseases
|
May 5, 2025
Application of the ENCALS predictive survival model in assessing the effect of the 24/44 inclusion criteria in FORTITUDE-ALS
Tyrell Simkins Lead, Jeremy M Shefner, Stuart Kupfer, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 99) with videos related to
Sort By:
Page
of 10
The American Journal of Medicine
|
September 4, 2012
Antihypertensive efficacy of hydrochlorothiazide vs chlorthalidone combined with azilsartan medoxomil
George L Bakris, Domenic Sica, William B White, et al.
Hypertension (Dallas, Tex. : 1979)
|
June 20, 2012
Azilsartan medoxomil plus chlorthalidone reduces blood pressure more effectively than olmesartan plus hydrochlorothiazide in stage 2 systolic hypertension
William C Cushman, George L Bakris, William B White, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)
|
April 27, 2012
Blood pressure-lowering efficacy of the fixed-dose combination of azilsartan medoxomil and chlorthalidone: a factorial study
Domenic Sica, George L Bakris, William B White, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
August 29, 2023
Relationship between quantitative strength and functional outcomes in the phase 2 FORTITUDE-ALS trial
Jeremy M Shefner, Bill Jacobsen, Stuart Kupfer, et al.
Thrombosis and Haemostasis
|
October 2, 2010
A dose-finding study with TAK-442, an oral factor Xa inhibitor, in patients undergoing elective total knee replacement surgery
Jeffrey I Weitz, Charlie Cao, Bengt I Eriksson, et al.
Clinical Pharmacokinetics
|
February 5, 2025
Effect of Hepatic Impairment or Renal Impairment on the Pharmacokinetics of Aficamten
Donghong Xu, Justin D Lutz, Punag Divanji, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
November 8, 2024
Plasma neurofilament analysis in VITALITY-ALS
Tyrell J Simkins, Stuart Kupfer, Fady I Malik, et al.
Clinical and Translational Science
|
April 9, 2025
Clinical Evaluation of the Effect of Aficamten on QT/QTc Interval in Healthy Participants
Neha Maharao, Donghong Xu, Tyrell J Simkins, et al.
The American Journal of Cardiology
|
September 26, 2006
Predictors of development of diabetes mellitus in patients with coronary artery disease taking antihypertensive medications (findings from the INternational VErapamil SR-Trandolapril STudy [INVEST])
Rhonda Cooper-Dehoff, Jerome D Cohen, George L Bakris, et al.
Journal of Neuromuscular Diseases
|
May 5, 2025
Application of the ENCALS predictive survival model in assessing the effect of the 24/44 inclusion criteria in FORTITUDE-ALS
Tyrell Simkins Lead, Jeremy M Shefner, Stuart Kupfer, et al.
Page
of 10